Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Longitudinal Study

被引：0
|
作者：
Gaurav, R.
Yahia-Cherif, L.
Mangone, G.
Pyatigorskaya, N.
Valabregue, R.
Ewenczyk, C.
Hutchison, M.
Corvol, J.
Vidailhet, M.
Lehericy, S.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1890
引用
收藏
页码：S789 / S790
页数：2
相关论文
共 50 条
  • [1] Longitudinal changes in Neuromelanin MRI Signal in Parkinson's Disease
    Gaurav, R.
    Pyatigorskaya, N.
    Ewenczyk, C.
    Valabregue, R.
    Evans, K.
    Arnulf, I.
    Vidailhet, M.
    Lehericy, S.
    MOVEMENT DISORDERS, 2018, 33 : S641 - S642
  • [2] Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker
    Gaurav, Rahul
    Yahia-Cherif, Lydia
    Pyatigorskaya, Nadya
    Mangone, Graziella
    Biondetti, Emma
    Valabregue, Romain
    Ewenczyk, Claire
    Hutchison, R. Matthew
    Cedarbaum, Jesse M.
    Corvol, Jean-Christophe
    Vidailhet, Marie
    Lehericy, Stephane
    MOVEMENT DISORDERS, 2021, 36 (07) : 1592 - 1602
  • [3] Characterization of neuromelanin MRI as a potential Parkinson's Disease biomarker in a multi-site longitudinal study
    Ingalhalikar, M.
    Pham, H.
    Bracoud, L.
    Hutchison, R. M.
    Evans, K.
    Dam, T.
    Sampat, M.
    Schaerer, J.
    Suhy, C. Conklin J.
    Scott, D.
    MOVEMENT DISORDERS, 2022, 37 : S78 - S80
  • [4] Neuromelanin in Parkinson's disease: A 3T MRI study
    Pietracupa, S.
    Martin-Bastida, A.
    Kaim, N. L.
    Schwarz, S.
    Auer, D.
    Berardelli, A.
    Piccini, P.
    MOVEMENT DISORDERS, 2016, 31 : S402 - S402
  • [5] Longitudinal changes in nigral neuromelanin in early, levodopa-treated Parkinson's disease
    Hwang, K.
    Langley, J.
    Kurra, N.
    Factor, S.
    Hu, X.
    Huddleston, D.
    MOVEMENT DISORDERS, 2021, 36 : S358 - S359
  • [6] MRI Signature of Neuromelanin and Iron Pathology in Parkinson's Disease
    Huddleston, Daniel
    Mahmoudi, Babak
    Langley, Jason
    Factor, Stewart
    Crosson, Bruce
    Hu, Xiaoping
    NEUROLOGY, 2019, 92 (15)
  • [7] A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease
    Matsuura, Keita
    Maeda, Masayuki
    Tabei, Ken-ichi
    Umino, Maki
    Kajikawa, Hiroyuki
    Satoh, Masayuki
    Kida, Hirotaka
    Tomimoto, Hidekazu
    NEUROSCIENCE LETTERS, 2016, 633 : 112 - 117
  • [8] Longitudinal MRI changes in Parkinson's disease patients with visual hallucinations
    Ibarretxe-Bilbao, N.
    Junqae, C.
    Ramirez-Ruiz, B.
    Marti, M. J.
    Valldeoriola, F.
    Bargallo, N.
    Tolosa, E.
    MOVEMENT DISORDERS, 2009, 24 : S194 - S194
  • [9] Neuromelanin-MRI of substantia nigra subregions in Parkinson's disease
    Borellini, L.
    Franco, G.
    Trujillo, P.
    Summers, P.
    Di Fonzo, A.
    Claassen, D. O.
    Costa, A.
    MOVEMENT DISORDERS, 2016, 31 : S432 - S433
  • [10] Optimization of a neuromelanin MRI protocol for use in a longitudinal study of substantia nigra depigmentation in early Parkinson's Disease (the InsIght-PD study)
    Hayat, T.
    Pszczolkowski, S.
    Xing, Y.
    Tench, C.
    Morgan, P.
    Evans, J.
    Auer, D.
    MOVEMENT DISORDERS, 2022, 37 : S74 - S75
12345